• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉瘤性蛛网膜下腔出血患者的重症监护管理:来自神经重症监护学会多学科共识会议的建议。

Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

机构信息

Neurology/Neurosurgery Intensive Care Unit, Washington University, St. Louis, MO, USA.

出版信息

Neurocrit Care. 2011 Sep;15(2):211-40. doi: 10.1007/s12028-011-9605-9.

DOI:10.1007/s12028-011-9605-9
PMID:21773873
Abstract

Subarachnoid hemorrhage (SAH) is an acute cerebrovascular event which can have devastating effects on the central nervous system as well as a profound impact on several other organs. SAH patients are routinely admitted to an intensive care unit and are cared for by a multidisciplinary team. A lack of high quality data has led to numerous approaches to management and limited guidance on choosing among them. Existing guidelines emphasize risk factors, prevention, natural history, and prevention of rebleeding, but provide limited discussion of the complex critical care issues involved in the care of SAH patients. The Neurocritical Care Society organized an international, multidisciplinary consensus conference on the critical care management of SAH to address this need. Experts from neurocritical care, neurosurgery, neurology, interventional neuroradiology, and neuroanesthesiology from Europe and North America were recruited based on their publications and expertise. A jury of four experienced neurointensivists was selected for their experience in clinical investigations and development of practice guidelines. Recommendations were developed based on literature review using the GRADE system, discussion integrating the literature with the collective experience of the participants and critical review by an impartial jury. Recommendations were developed using the GRADE system. Emphasis was placed on the principle that recommendations should be based not only on the quality of the data but also tradeoffs and translation into practice. Strong consideration was given to providing guidance and recommendations for all issues faced in the daily management of SAH patients, even in the absence of high quality data.

摘要

蛛网膜下腔出血 (SAH) 是一种急性脑血管事件,可对中枢神经系统造成严重影响,并对其他多个器官产生深远影响。SAH 患者通常被收入重症监护病房,并由多学科团队进行护理。由于缺乏高质量的数据,导致出现了许多管理方法,但对于如何选择这些方法,只有有限的指导。现有的指南强调了危险因素、预防、自然史和再出血的预防,但对涉及 SAH 患者护理的复杂重症监护问题讨论有限。神经重症监护学会组织了一次关于 SAH 重症监护管理的国际、多学科共识会议,以满足这一需求。根据他们的出版物和专业知识,从神经重症监护、神经外科、神经病学、介入神经放射学和神经麻醉学领域招募了来自欧洲和北美的专家。四名经验丰富的神经重症监护专家因在临床研究和实践指南制定方面的经验而被选为评审团成员。建议是根据 GRADE 系统的文献回顾、结合参与者的集体经验进行讨论以及由公正的评审团进行批判性审查而制定的。建议是使用 GRADE 系统制定的。重点是建议不仅应基于数据的质量,还应基于权衡和转化为实践。即使在缺乏高质量数据的情况下,也非常重视为 SAH 患者日常管理中面临的所有问题提供指导和建议。

相似文献

1
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.动脉瘤性蛛网膜下腔出血患者的重症监护管理:来自神经重症监护学会多学科共识会议的建议。
Neurocrit Care. 2011 Sep;15(2):211-40. doi: 10.1007/s12028-011-9605-9.
2
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.国际神经危重病多模态监测多学科共识会议共识总结声明:来自神经危重病学会和欧洲危重病医学会的医疗保健专业人员的声明。
Intensive Care Med. 2014 Sep;40(9):1189-209. doi: 10.1007/s00134-014-3369-6. Epub 2014 Aug 20.
3
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.神经重症监护多模态监测国际多学科共识会议共识总结声明:神经重症监护学会和欧洲重症监护医学学会给医疗专业人员的声明
Neurocrit Care. 2014 Dec;21 Suppl 2(Suppl 2):S1-26. doi: 10.1007/s12028-014-0041-5.
4
Diagnosis and Management of Subarachnoid Hemorrhage.蛛网膜下腔出血的诊断与管理
Continuum (Minneap Minn). 2015 Oct;21(5 Neurocritical Care):1263-87. doi: 10.1212/CON.0000000000000217.
5
The risks of blood transfusion in patients with subarachnoid hemorrhage.蛛网膜下腔出血患者输血的风险
Neurocrit Care. 2012 Apr;16(2):343-5; author reply 346-9. doi: 10.1007/s12028-011-9654-0.
6
Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.大面积半球梗死管理的循证指南:神经重症监护学会和德国神经重症监护与急诊医学学会给医疗保健专业人员的声明
Neurocrit Care. 2015 Feb;22(1):146-64. doi: 10.1007/s12028-014-0085-6.
7
Intensive care of aneurysmal subarachnoid hemorrhage: an international survey.动脉瘤性蛛网膜下腔出血的重症监护:一项国际调查。
Intensive Care Med. 2009 Sep;35(9):1556-66. doi: 10.1007/s00134-009-1533-1. Epub 2009 Jun 17.
8
Managing subarachnoid hemorrhage in the neurocritical care unit.神经重症监护病房的蛛网膜下腔出血管理。
Neurosurg Clin N Am. 2013 Jul;24(3):321-37. doi: 10.1016/j.nec.2013.02.008. Epub 2013 Apr 24.
9
[Guidelines for diagnosis and management of aneurysmal subarachnoid hemorrhage: top issues and prospective].[动脉瘤性蛛网膜下腔出血的诊断和管理指南:首要问题与展望]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Jul;44(4):357-60. doi: 10.3785/j.issn.1008-9292.2015.07.01.
10
Subarachnoid Hemorrhage.蛛网膜下腔出血
Continuum (Minneap Minn). 2018 Dec;24(6):1623-1657. doi: 10.1212/CON.0000000000000679.

引用本文的文献

1
Clinical implications and prognostic value of mastoid effusion in the management of aneurysmal subarachnoid hemorrhage.乳突积液在动脉瘤性蛛网膜下腔出血治疗中的临床意义及预后价值
Front Neurol. 2025 Aug 6;16:1603869. doi: 10.3389/fneur.2025.1603869. eCollection 2025.
2
Nimodipine after aneurysmal subarachnoid hemorrhage: shortened treatment in an unselected patient cohort.尼莫地平用于动脉瘤性蛛网膜下腔出血:在未选择的患者队列中缩短治疗时间
Brain Spine. 2025 Jul 28;5:104376. doi: 10.1016/j.bas.2025.104376. eCollection 2025.
3
Acute care of aneurysmal subarachnoid hemorrhage: practical consensus statement from a multidisciplinary group of German-speaking neurointensivists and neuroradiologists on behalf of the DIVI neurology section.

本文引用的文献

1
Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage.脑梗死发生率降低与动脉瘤性蛛网膜下腔出血后功能结局改善相关。
J Cereb Blood Flow Metab. 2011 Jul;31(7):1545-53. doi: 10.1038/jcbfm.2011.56. Epub 2011 Apr 20.
2
A comparison of intravascular and surface cooling techniques in comatose cardiac arrest survivors.血管内和体表冷却技术在昏迷性心脏骤停幸存者中的比较。
Crit Care Med. 2011 Mar;39(3):443-9. doi: 10.1097/CCM.0b013e318206b80f.
3
Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus.
动脉瘤性蛛网膜下腔出血的急性治疗:一组德语区神经重症监护医师和神经放射科医师代表DIVI神经科发布的实用共识声明
Neurol Res Pract. 2025 Jul 30;7(1):54. doi: 10.1186/s42466-025-00407-x.
4
First-day intracranial pressure correlates with ICU mortality in subarachnoid hemorrhage patients: an analysis of the MIMIC-IV database.蛛网膜下腔出血患者首日颅内压与重症监护病房死亡率的相关性:MIMIC-IV数据库分析
Front Neurol. 2025 Jul 2;16:1594680. doi: 10.3389/fneur.2025.1594680. eCollection 2025.
5
Dose-response and infusion duration of intra-arterial nimodipine in cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a single-center case series.动脉瘤性蛛网膜下腔出血后脑血管痉挛患者动脉内注射尼莫地平的剂量反应及输注持续时间:一项单中心病例系列研究
Neuroradiology. 2025 Jul 16. doi: 10.1007/s00234-025-03699-7.
6
Does duration of nimodipine therapy impact outcome in aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.尼莫地平治疗时长对动脉瘤性蛛网膜下腔出血结局有何影响:系统评价与荟萃分析
Neurosurg Rev. 2025 Jun 28;48(1):531. doi: 10.1007/s10143-025-03672-1.
7
Comparative analysis of two standardised protocols for prevention of vasospasm following aneurysmal subarachnoid haemorrhage: A retrospective pilot study.两种标准化动脉瘤性蛛网膜下腔出血后血管痉挛预防方案的比较分析:一项回顾性试点研究。
Eur J Anaesthesiol Intensive Care. 2025 May 9;4(3):e0073. doi: 10.1097/EA9.0000000000000073. eCollection 2025 Jun.
8
Association of Anaemia With Higher Mortality and Disability After Subarachnoid Haemorrhage: A Single-Centre Cohort Study.蛛网膜下腔出血后贫血与较高死亡率和残疾率的关联:一项单中心队列研究
Cureus. 2025 Apr 26;17(4):e83031. doi: 10.7759/cureus.83031. eCollection 2025 Apr.
9
MiR-34c Is Predictive of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.微小RNA-34c可预测蛛网膜下腔出血后迟发性脑缺血
Res Sq. 2025 Apr 1:rs.3.rs-6198784. doi: 10.21203/rs.3.rs-6198784/v1.
10
Serum Desmosine Levels Might Be Associated with the Size of Ruptured Cerebral Aneurysms in Patients with Aneurysmal Subarachnoid Hemorrhage-A Preliminary Study.血清去甲胍丁胺水平可能与动脉瘤性蛛网膜下腔出血患者破裂脑动脉瘤的大小相关——一项初步研究。
J Clin Med. 2025 Mar 18;14(6):2056. doi: 10.3390/jcm14062056.
短期抗纤维蛋白溶解治疗在蛛网膜下腔出血早期动脉瘤治疗前:对再出血、脑缺血和脑积水的影响。
Neurosurgery. 2010 Oct;67(4):935-9; discussion 939-40. doi: 10.1227/NEU.0b013e3181ebaa36.
4
Outcomes after nontraumatic subarachnoid hemorrhage at hospitals offering angioplasty for cerebral vasospasm: a national level analysis in the United States.美国医院行血管成形术治疗脑动脉痉挛治疗非创伤性蛛网膜下腔出血的结果:国家层面分析。
Neurocrit Care. 2011 Aug;15(1):34-41. doi: 10.1007/s12028-010-9423-5.
5
Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group.定义动脉瘤性蛛网膜下腔出血后的迟发性脑缺血作为临床试验和观察性研究中的结局事件:一个多学科研究小组的建议。
Stroke. 2010 Oct;41(10):2391-5. doi: 10.1161/STROKEAHA.110.589275. Epub 2010 Aug 26.
6
Intracortical EEG for the detection of vasospasm in patients with poor-grade subarachnoid hemorrhage.皮层脑电图在检测蛛网膜下腔出血分级差的患者血管痉挛中的应用。
Neurocrit Care. 2010 Dec;13(3):355-8. doi: 10.1007/s12028-010-9414-6.
7
Continuous cardiac output and near-infrared spectroscopy monitoring to assist in management of symptomatic cerebral vasospasm after subarachnoid hemorrhage.连续心输出量和近红外光谱监测辅助管理蛛网膜下腔出血后症状性脑血管痉挛。
Neurocrit Care. 2010 Dec;13(3):331-8. doi: 10.1007/s12028-010-9383-9.
8
Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage.血管舒张与神经保护:蛛网膜下腔出血中的镁元素传奇
Crit Care Med. 2010 May;38(5):1382-4. doi: 10.1097/CCM.0b013e3181da4672.
9
Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.静脉硫酸镁治疗动脉瘤性蛛网膜下腔出血(IMASH):一项随机、双盲、安慰剂对照、多中心 III 期临床试验。
Stroke. 2010 May;41(5):921-6. doi: 10.1161/STROKEAHA.109.571125. Epub 2010 Apr 8.
10
Inferior vena cava distensibility as a predictor of fluid responsiveness in patients with subarachnoid hemorrhage.下腔静脉顺应性可预测蛛网膜下腔出血患者的液体反应性。
Neurocrit Care. 2010 Aug;13(1):3-9. doi: 10.1007/s12028-010-9356-z.